Tag: Biotech
R&D Roundup: ‘Twisted light’ lasers, prosthetic vision advances and robot-trained dogs
I see far more research articles than I could possibly write up. This column collects the most interesting of those papers and advances, along with notes on why they may prove important in the world of tech and startups. In this edition: a new type of laser emitter that uses…
Read More
Fitbit’s Chinese rival Amazfit mulls a transparent, self-disinfecting mask
The COVID-19 pandemic has ushered in a wave of Chinese companies with manufacturing operations to produce virus-fighting equipment: Shenzhen-based electric vehicle giant BYD quickly moved to launch what it claims to be the world’s largest mask plant; Hangzhou-based voice intelligence startup Rokid is making thermal imaging glasses targeted at the US…
Read More
Everylwell gains first FDA authorization for a standalone at-home COVID-19 test sample collection kit
Everlywell was one of the first startups to announce that it was working on a self-administered, at-home COVID-19 diagnostic kit, but it initially sought out to ship kits before regulators made clear that this was not in line with its guidelines. Everlywell then became intent on working with the FDA…
Read More
Sorrento finds a coronavirus antibody that blocks viral infection 100% in preclinical lab experiments
Therapeutics company Sorrento has made what it believes could be a breakthrough in potential treatment of SARS-CoV-2, the virus that leads to COVID-19. The company released details of its preclinical research on Friday, announcing that it has found an antibody that provides “100% inhibition of SARS-CoV-2 virus infection of healthy…
Read More
Biotherapeutics startup Hummingbird Bioscience brings its total Series B funding to $25 million
Hummingbird Bioscience, a startup focused on developing new treatments for cancer and other diseases, announced today it has added $6 million to its previously announced Series B, bringing the round’s total to $25 million. The extension was led by SK Holdings, and included participation from returning investors including Heritas Capital…
Read More
Health APIs usher in the patient revolution we have been waiting for
Rish Joshi Contributor Rish is an entrepreneur and investor. Previously, he was a VC at Gradient Ventures (Google’s AI fund), co-founded a fintech startup building an analytics platform for SEC filings and worked on deep-learning research as a graduate student in computer science at MIT. More posts by this contributor…
Read More